Welcome to Trends-in-Medicine, offering independent, cutting-edge articles and information on drugs and devices in development. Our subscribers have access to news and analysis on the latest data, regulatory issues, and trends of interest to the healthcare community.

Bulletin: Coronavirus Update 5/20

Up to now, the focus in the coronavirus pandemic has been on preventing, diagnosing, and treating Covid-19 – on ventilators, testing, and masks. However, as the number of hospitalized Covid-19 patients drops in the U.S , shelter-at-home orders are being gradually lifted, and the economy is slowly re-opening. Thus, this report focuses on two other topics that deserve some attention: (1) The outlook for elective surgery procedures, and (2) the long-term consequences (if any) for Covid-19 survivors.

ASCO 2020 Preview

There are always so many trials reported at the American Society of Clinical Oncology (ASCO) that it is difficult not to miss something. Here is a quick look at some of the key studies – and we apologize for any we missed – to be presented at this year’s ASCO virtual meeting May 29-31, 2020. The first lists are by company/drug, sorted by Phase I-I/II-II-III. Below all of that is a list of the Phase III trials by cancer type. We hope this helps in planning, at least in some small way.

Bulletin: Coronavirus Update 5/7

Mitigation efforts aimed at slowing the SARS-CoV-2 virus and Covid-19, the disease it causes, appear to be working in the U.S. and in many European countries. The peak likely has been reached in the U.S and in many European countries, and steps – mostly baby steps – are being taken to re-open economies. It seems increasingly unlikely that President Trump’s prediction of a V-shaped U.S. recovery will occur in the U.S. or elsewhere. The outlook is for either a U-shaped recovery or a W-shaped recovery, if there is a second wave of Covid-19 this fall.

Bulletin: Coronavirus Update 4/27

The SARS-CoV-2 virus and Covid-19, the disease it causes, continue to have much of the world on pause, but there are small signs of the beginning of the end. In the U.S. and most of Europe, the rate of Covid-19 cases appears to have peaked/ plateaued and, in some places, started a slow decline. Countries, states, and localities are starting to try to figure out how to safely get their economy restarted again. However, it is clear that this will not be quick, and there will be no sudden return to the old normal. And s far there are no therapies that have shown significant efficacy.

Bulletin: Coronavirus Update 4/16

The SARS-CoV-2 virus and the disease it causes continue to have much of the world on pause. In the U.S. and most of Europe, the rate of infection appears to have peaked/plateaued, and countries are trying to figure out how to safely get things restarted again. This report is a broad overview of what is happening around the world, in the U.S., and in individual states, covering everything from testing to drugs in development and more.

Bulletin: Coronavirus Update 4/12

The U.S. now has more cases of Covid-19 than any other country, 557,571, and New York City accounts for 35% of those cases. Franc, Italy, and Spain have plateaued in terms of additional cases per day, a key metric.

Bulletin: Coronavirus Update 4/9

The U.S. is being hit hard by the coronavirus. The death toll is terrible, but it looks like the fatalities will be far below earlier estimates -- because Americans are staying home. However, it doesn't look like things will go back to normal soon.